Xultophy 100/3.6
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0169-2911 -
Package NDC
0169-2911-15 -
Application number
BLA208583 -
SPL ID
7ade72ef-d354-430d-afad-3b63b95f5b39 -
SPL set ID
21335fe4-d395-4501-ac2a-2f20d7520da9 -
UNII
54Q18076QB -
UNII
839I73S42A -
RxCUI
1860167 -
RxCUI
1860172
What the source publishes
- Labeler
- Novo Nordisk
- Active ingredients
- insulin degludec and liraglutide
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Xultophy 100/3.6",
"splId": "7ade72ef-d354-430d-afad-3b63b95f5b39",
"labels": [
{
"setId": "21335fe4-d395-4501-ac2a-2f20d7520da9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21335fe4-d395-4501-ac2a-2f20d7520da9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21335fe4-d395-4501-ac2a-2f20d7520da9"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Novo Nordisk",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTIC",
"package_ndc": "0169-2911-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20161121"
}
],
"productId": "0169-2911_7ade72ef-d354-430d-afad-3b63b95f5b39",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0169-2911",
"deaSchedule": null,
"genericName": "insulin degludec and liraglutide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INSULIN DEGLUDEC",
"strength": "100 [iU]/mL"
},
{
"name": "LIRAGLUTIDE",
"strength": "3.6 mg/mL"
}
],
"applicationNumber": "BLA208583",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20161121",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0011417",
"N0000175453",
"N0000178480",
"M0160181",
"N0000020058"
],
"unii": [
"54Q18076QB",
"839I73S42A"
],
"rxcui": [
"1860167",
"1860172"
],
"spl_set_id": [
"21335fe4-d395-4501-ac2a-2f20d7520da9"
],
"pharm_class_cs": [
"Insulin [CS]",
"Glucagon-Like Peptide 1 [CS]"
],
"pharm_class_epc": [
"Insulin Analog [EPC]",
"GLP-1 Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
],
"manufacturer_name": [
"Novo Nordisk"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0169-2911_7ade72ef-d354-430d-afad-3b63b95f5b39"